Erectile Dysfunction
Conditions
Interventions
An extract containing ginseng and maca is administered for 8 weeks.
Placebo tablets are administered for 8 weeks.
Sponsors
DHC Corporation
Suidobashi Medical Clinic
Eligibility
Sex/Gender
Male
Inclusion criteria
Inclusion criteria: - Age: more than or equal to 20 years at the time of providing informed consent - Healthy individuals or male subjects with mild to moderate ED, erectile dysfunction. - Individuals who have never experienced psychological and critical diseases. - Individuals who have the ability to provide written informed consent.
Exclusion criteria
Exclusion criteria: - Subjects who have an inappropriate clinical history for efficacy and safety assessment in the study (such as drug abuse, alcoholism, and the disease of heart, liver, kidney, lungs, eye, blood etc) and who is taking any drugs. - Subjects judged to be inappropriate for the study by the investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary endpoint is evaluation of safety as phase I trial. An evaluation of adverse events. | — |
Secondary
| Measure | Time frame |
|---|---|
| Efficacy for erectile dysfunction as phase II study. Effects on subjective well-being and erectile dysfunction were evaluated with the International Index of Erectile Function (IIEF-5). | — |
Countries
Japan
Contacts
Public ContactSeika Kamohara MD, PhD
DHC Corporation Division of Research Adviser
Outcome results
None listed